[go: up one dir, main page]

DE10299023I1 - Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff - Google Patents

Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff

Info

Publication number
DE10299023I1
DE10299023I1 DE2002199023 DE10299023C DE10299023I1 DE 10299023 I1 DE10299023 I1 DE 10299023I1 DE 2002199023 DE2002199023 DE 2002199023 DE 10299023 C DE10299023 C DE 10299023C DE 10299023 I1 DE10299023 I1 DE 10299023I1
Authority
DE
Germany
Prior art keywords
antineoplastic effect
antineoplastic
potentiating
effect
enhances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2002199023
Other languages
English (en)
Other versions
DE10299023I2 (de
Inventor
Junji Uchida
Hiroyuki Okabe
Teiji Takechi
Setsuo Takeda
Yuji Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17034249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10299023(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE10299023I1 publication Critical patent/DE10299023I1/de
Application granted granted Critical
Publication of DE10299023I2 publication Critical patent/DE10299023I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE10299023C 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff Active DE10299023I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23871990 1990-09-07
PCT/JP1991/001187 WO1992004028A1 (fr) 1990-09-07 1991-09-05 Potentialisateur d'effets antineoplasique et agent antineoplasique

Publications (2)

Publication Number Publication Date
DE10299023I1 true DE10299023I1 (de) 2003-06-05
DE10299023I2 DE10299023I2 (de) 2010-05-06

Family

ID=17034249

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69121551T Expired - Lifetime DE69121551T2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE10299023C Active DE10299023I2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69121551T Expired - Lifetime DE69121551T2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Country Status (14)

Country Link
EP (1) EP0500953B1 (de)
JP (1) JP2557303B2 (de)
KR (1) KR0146952B1 (de)
AT (1) ATE141506T1 (de)
AU (1) AU644684B2 (de)
CA (1) CA2071819A1 (de)
DE (2) DE69121551T2 (de)
DK (1) DK0500953T3 (de)
ES (1) ES2091941T3 (de)
GR (1) GR3021003T3 (de)
HU (1) HU211739A9 (de)
LU (1) LU90791I2 (de)
NL (1) NL300041I2 (de)
WO (1) WO1992004028A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310573A (ja) * 1992-05-01 1993-11-22 Dotsuto:Kk リウマチ治療薬
US5643191A (en) * 1995-01-26 1997-07-01 Sorin Biomedical Inc. Cardioplegia delivery system and method for converting from warm cardioplegia to cold cardioplegia
US5702358A (en) * 1995-02-23 1997-12-30 Sorin Biomedical Inc. Cardioplegia delivery apparatus and method of use
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
WO2000021956A1 (fr) * 1998-10-12 2000-04-20 Leonidov Nikolai B Nouvelle modification cristalline de 5-fluoro-1-(tetrahydro-2-furyl)-uracyle, et composes complexes a base de cette modification ayant une activite antitumorale
PL1604991T3 (pl) * 2003-03-14 2009-02-27 Taiho Pharmaceutical Co Ltd Środek wzmacniający działanie przeciwnowotworowe i środek przeciwnowotworowy
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
AU2008356312B2 (en) 2008-05-12 2015-04-09 Shizuoka Prefecture Antitumor agent, kit, and method for treating cancer
KR102258514B1 (ko) * 2019-09-23 2021-05-31 연세대학교 산학협력단 신규한 다층형 좌약 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953885B2 (ja) * 1978-02-10 1984-12-27 大鵬薬品工業株式会社 抗腫瘍剤組成物
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
JPS5780319A (en) * 1980-11-06 1982-05-19 Taiho Yakuhin Kogyo Kk Anti-tumor agent having reduced toxicity

Also Published As

Publication number Publication date
KR0146952B1 (ko) 1998-08-17
GR3021003T3 (en) 1996-12-31
NL300041I1 (nl) 2001-06-01
WO1992004028A1 (fr) 1992-03-19
NL300041I2 (nl) 2002-02-01
EP0500953A4 (en) 1993-04-21
HU211739A9 (en) 1995-12-28
CA2071819A1 (en) 1992-03-08
JP2557303B2 (ja) 1996-11-27
EP0500953B1 (de) 1996-08-21
LU90791I2 (fr) 2001-10-08
DK0500953T3 (da) 1997-01-06
ATE141506T1 (de) 1996-09-15
ES2091941T3 (es) 1996-11-16
DE10299023I2 (de) 2010-05-06
KR927002224A (ko) 1992-09-03
AU644684B2 (en) 1993-12-16
DE69121551D1 (de) 1996-09-26
DE69121551T2 (de) 1997-01-02
AU8447991A (en) 1992-03-30
EP0500953A1 (de) 1992-09-02

Similar Documents

Publication Publication Date Title
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
ATE136542T1 (de) Pyrimidine und deren pharmazeutisch brauchbare salze und deren verwendung als arzneimittel
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
DE69318031D1 (de) Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
ES2087916T3 (es) Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo.
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE173627T1 (de) Medizinische zusammensetzung
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
DE10299023I1 (de) Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff
BG100599A (en) Antiviral form and therapeutical method
MY104521A (en) Treatment of depression.
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
ATE70977T1 (de) Medikamente fuer die behandlung von rheumatoider arthritis.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
KR890007737A (ko) 진토작용을 하는 약제
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
PT728002E (pt) Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
KR890001555A (ko) 요산 배설용 조성물